Literature DB >> 19420073

Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes.

Yaron Rotman1, T Jake Liang.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19420073      PMCID： PMC2708610          DOI： 10.1128/JVI.00191-09

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  132 in total

1.  Risk of hepatitis C virus transmission following percutaneous exposure in healthcare workers.

Authors:  G De Carli; V Puro; G Ippolito
Journal:  Infection       Date:  2003-12       Impact factor: 3.553

2.  Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women.

Authors:  Marek J Nowicki; Tomasz Laskus; Georgia Nikolopoulou; Marek Radkowski; Jeffrey Wilkinson; Wenbo B Du; Jorge Rakela; Andrea Kovacs
Journal:  J Infect Dis       Date:  2005-09-29       Impact factor: 5.226

3.  Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis.

Authors:  Melissa Farmer Miller; Clinton Haley; Margaret James Koziel; Christopher F Rowley
Journal:  Clin Infect Dis       Date:  2005-07-22       Impact factor: 9.079

4.  Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.

Authors:  Giorgio Antonucci; Enrico Girardi; Alessandro Cozzi-Lepri; Maria Rosaria Capobianchi; Andrea De Luca; Massimo Puoti; Enzo Petrelli; Giuseppe Carnevale; Giuliano Rizzardini; Paolo Antonio Grossi; Paolo Viganò; Maria Cristina Moioli; Fabrizio Carletti; Mariacarmela Solmone; Giuseppe Ippolito; Antonella D'Arminio Monforte
Journal:  Clin Infect Dis       Date:  2005-05-05       Impact factor: 9.079

5.  Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.

Authors:  Dominique Salmon-Ceron; Charlotte Lewden; Philippe Morlat; Sibylle Bévilacqua; Eric Jougla; Fabrice Bonnet; Laurence Héripret; Dominique Costagliola; Thierry May; Geneviève Chêne
Journal:  J Hepatol       Date:  2005-06       Impact factor: 25.083

6.  Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy.

Authors:  Firouzé Bani-Sadr; Fabrice Carrat; Stanislas Pol; Ravy Hor; Eric Rosenthal; Cécile Goujard; Patrice Morand; Françoise Lunel-Fabiani; Dominique Salmon-Ceron; Lionel Piroth; Gilles Pialoux; Michèle Bentata; Patrice Cacoub; Christian Perronne
Journal:  J Acquir Immune Defic Syndr       Date:  2005-09-01       Impact factor: 3.731

7.  Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.

Authors:  A H Mohsen; S Murad; P J Easterbrook
Journal:  HIV Med       Date:  2005-05       Impact factor: 3.180

8.  HCV persistence and immune evasion in the absence of memory T cell help.

Authors:  Arash Grakoui; Naglaa H Shoukry; David J Woollard; Jin-Hwan Han; Holly L Hanson; John Ghrayeb; Krishna K Murthy; Charles M Rice; Christopher M Walker
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

9.  Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4.

Authors:  Stacey R Vlahakis; Angelina Villasis-Keever; Timothy S Gomez; Gary D Bren; Carlos V Paya
Journal:  J Infect Dis       Date:  2003-11-18       Impact factor: 5.226

10.  Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection.

Authors:  Nazifa Qurishi; Christina Kreuzberg; Guido Lüchters; Wolfgang Effenberger; Bernd Kupfer; Tilman Sauerbruch; Jürgen K Rockstroh; Ulrich Spengler
Journal:  Lancet       Date:  2003-11-22       Impact factor: 79.321
View more
  55 in total

Review 1.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

Review 2.  Substance abuse, HIV-1 and hepatitis.

Authors:  Nirzari Parikh; Michael R Nonnemacher; Vanessa Pirrone; Timothy Block; Anand Mehta; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2012-10       Impact factor: 1.581

3.  Predicting the probability of experiencing clinically significant drug-drug interactions involving boceprevir-containing hepatitis C therapy among patients coinfected with hepatitis C and HIV.

Authors:  Nimish Patel; Michael Veve; Mona Nasiri; Steven Bliss; Louise-Anne McNutt; Victoria Lazariu; Christopher Miller
Journal:  AIDS Patient Care STDS       Date:  2014-08-05       Impact factor: 5.078

4.  Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania.

Authors:  Barrot H Lambdin; Jennifer Lorvick; Jessie K Mbwambo; John Rwegasha; Saria Hassan; Paula Lum; Alex H Kral
Journal:  Int J Drug Policy       Date:  2017-06-17

5.  Transmission and evolution of hepatitis C virus in HCV seroconverters in HIV infected subjects.

Authors:  Chengli Shen; Phalguni Gupta; Xiaochuan Xu; Anwesha Sanyal; Charles Rinaldo; Eric Seaberg; Joseph B Margolick; Otoniel Martinez-Maza; Yue Chen
Journal:  Virology       Date:  2013-12-22       Impact factor: 3.616

6.  HIV Infection Status as a Predictor of Hepatitis C Virus RNA Testing in Primary Care.

Authors:  Anthony K Yartel; Rebecca L Morgan; David B Rein; Kimberly Ann Brown; Natalie B Kil; Omar I Massoud; Michael B Fallon; Bryce D Smith
Journal:  Am J Prev Med       Date:  2015-04-18       Impact factor: 5.043

7.  Comparison of Hepatitis C Virus RNA and antibody detection in dried blood spots and plasma specimens.

Authors:  E Kainne Dokubo; Jennifer Evans; Valerie Winkelman; Sherri Cyrus; Leslie H Tobler; Alice Asher; Alya Briceno; Kimberly Page
Journal:  J Clin Virol       Date:  2014-01-27       Impact factor: 3.168

Review 8.  Challenges in managing HIV in people who use drugs.

Authors:  Adeeba Kamarulzaman; Frederick L Altice
Journal:  Curr Opin Infect Dis       Date:  2015-02       Impact factor: 4.915

9.  Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.

Authors:  Sandra Olukemi Ogwu-Richard; David Ajiboye Ojo; Olusola Abiodun Akingbade; Iheanyi Omezuruike Okonko
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

Review 10.  HIV-1, HCV and alcohol in the CNS: potential interactions and effects on neuroinflammation.

Authors:  Peter S Silverstein; Santosh Kumar; Anil Kumar
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.